Shalini , Kumar, et al. “To Assess the Efficacy and Safety of Fixed-Dose Combination of Teneligliptin and Pioglitazone (Tiban P) in Iraqi Patients With Type 2 Diabetes Mellitus”. International Journal of Research in Pharmacy and Life Sciences, vol. 12, no. 02, Aug. 2024, pp. 31-37, https://doi.org/10.30904/j.ijrpls.2024.4722.